文献速递乳房整形与再造美容整形

比较四个国家乳房植入物注册中心中的20万枚乳房植入物和8.5万名患者

Comparing 200,000 Breast Implants and 85,000 Patients over Four National Breast Implant Registries.
PubMed 文献 · Plast Reconstr Surg · 2023-07-27

该研究首次合并澳大利亚、荷兰、瑞典和美国四个国家乳房植入物注册中心的真实世界数据,共纳入207,189枚乳房植入物,其中符合条件子人群111,590枚(7%为乳房再造,93%为隆乳)。结果显示各国全国覆盖率在3%至98%之间,2年累积翻修率在乳房再造后为6%至16%,隆乳后为1%至4%。

要点

  • 四个国家注册中心数据首次成功合并,共207,189枚乳房植入物,全国覆盖率3%至98%不等。
  • 子人群111,590枚植入物中7%为乳房再造、93%为隆乳,患者平均年龄再造组41至49岁、隆乳组31至36岁。
  • 2年累积翻修率再造后6%至16%、隆乳后1%至4%,各国植入物偏好和感染控制措施登记存在差异。

核心结论

  • 首次合并四个独立的国家乳房植入物注册中心数据,是优化国际乳房植入物监测、循证决策和患者安全的重要一步。

研究设计与样本

  • 使用澳大利亚、荷兰、瑞典和美国四个现行活跃的国家乳房植入物注册中心的真实世界数据,纳入所有永久性乳房植入物。
  • 随后选取2015年至2018年间所有注册中心均存在的子人群,仅包括无既往乳房装置手术患者初次乳房再造或隆乳术中置入的永久性乳房植入物。
  • 分析全国覆盖率、患者和植入物特征、感染控制措施及翻修发生率。

主要发现

  • 共登记207,189枚乳房植入物,全国覆盖率在3%至98%之间。
  • 子人群包括111,590枚植入物,其中7%为乳房再造,93%为隆乳。
  • 各注册中心乳房再造患者平均年龄在41至49岁之间(P < 0.001),隆乳患者平均年龄在31至36岁之间(P < 0.001)。
  • 各国植入物偏好随国家和年份存在差异,感染控制措施在澳大利亚登记最频繁。
  • 2年累积翻修率在乳房再造后为6%至16%,在隆乳后为1%至4%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Growing awareness about breast implant-related adverse events has stimulated the demand for large, independent data resources. For this, data from breast implant registries could be combined. However, that has never been achieved yet. METHODS: Real-world data from four currently active national breast implant registries were used. All permanent breast implants from the Australian, Dutch, Swedish, and American registries were included. A subpopulation present across all registries between 2015 and 2018 was subsequently selected, including only permanent breast implants inserted during primary surgery for breast reconstruction or augmentation in patients without previous breast device surgery. Nationwide coverage, patient and implant characteristics, infection control measures, and revision incidences were analyzed. RESULTS: A total of 207,189 breast implants were registered. Nationwide coverage varied between 3% and 98%. The subpopulation included 111,590 implants (7% reconstruction, 93% augmentation). Across the registries, mean patient age varied between 41 and 49 years ( P < 0.001) for reconstruction and 31 and 36 years ( P < 0.001) for augmentation. Variation was observed in implant preferences across the countries and over the years. Infection control measures were most frequently registered in Australia. Cumulative revision incidence at 2 years ranged from 6% to 16% after reconstruction and from 1% to 4% after augmentation. CONCLUSIONS: For the first time, independent, national, registry-based data from four breast implant registries were combined. This is a powerful step forward in optimizing international breast implant monitoring, evidence-based decision-making, and patient safety.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Becherer BE, Hopper I, Cooter RD, et al. Comparing 200,000 Breast Implants and 85,000 Patients over Four National Breast Implant Registries. Plast Reconstr Surg. 2023. PMID: 36728275. doi:10.1097/PRS.0000000000010208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。